Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 3, 1997, Pages 363-371

  Huang, Nai Kuei ^a   Tseng, Ching Jiunn ^a   Wong, Chih Shung ^a   Tung, Che Se ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

cortex; DOPAC; glutamate; morphine; nucleus accumbens; striatum

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; GLUTAMIC ACID; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALGESICS, OPIOID; ANIMALS; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; DRUG EVALUATION, PRECLINICAL; GLUTAMIC ACID; MALE; MICRODIALYSIS; MORPHINE; NALOXONE; NERVE ENDINGS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0030989461     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00236-5     Document Type: Article

References (43)

1. Acquas, E.; Di Chiara, G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58:1620-1625; 1992.
2. Aghajaniann G. K.; Kogan, J. H.; Moghaddam, B. Opiate withdrawal increases glutamate and aspartate efflux in locus coeruleus: an in vivo microdialysis study. Brain Res. 636:126-130; 1994.
3. Akaoka, H.; Aston-Jones, G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11(12):3830-3839; 1991.
4. Alexander, G. E.; DeLong, M. R.; Strick, P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 9:357-381; 1986.
5. Allison, L. A.; Mayer, G. S.; Shoup, R. E. o-phthalaldehyde derivatives of amines for high-speed liquid chromatography/electrochemistry. Anal. Chem. 56:1089-1096; 1984.
6. Beaudet, A.; Descarries, L. The monoamine innervation of rat cerebral cortex: Synaptic and non-synaptic relationships. Neurosci. 3:851-860; 1978.
7. Beckstead, R. M. An auto radiographic examination of corticocortical and subcortical projections of the mediodorsal projection (prefrontal) in the rat. J. Comp. Neurol. 184:43-56; 1979.
8. Bouyer, J. J.; Park, D. H.; Joh, T. H.; Pickel, V. M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302:267-273; 1984.
9. Burns, L. H.; Everitt, B. J.; Kelley, A. E.; Robbins, T. W. Glutamate-dopamine interactions in the ventral striatum: Role in locomotor activity and responding with conditioned reinforcement. Psychopharmaco. 115:516-528; 1994.
10. Carlsson, A. On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity; J. Neural. Transm. 40:1-12; 1993.
11. Chavez-Noriega, L.; Patino, P.; Garcia-Munoz, M. Excitability changes induced in the striatal dopamine-containing terminals following frontal cortex stimulation. Brain Res. 379:300-306; 1986.
12. Collingridge, G.L.; Singer, W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. 11:290-296; 1990.
13. Di Chiara, G.; Imperato, A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1067-1074; 1988a.
14. Di Chiara, G.; Imperato, A. Drugs of abuse preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85:5274-5277; 1988b.
15. Engberg, G.; Hajos, M. Alcohol withdrawal reaction as a result of adaptive changes of excitatory amino acid receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 346:437-443; 1992.
16. Faden, A. I. Dynorphine increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J. Neurosci. 12:425-431; 1992.
17. Fleming, W.; Westfall, D. P. Adaptive supersensitivity. In: Trendelenburg, U.; Weiner, N., eds. Handbook of experimental pharmacology 90/I, Catecholamines I. Heidelberg: Springer-Verlag press; 1988: 509.
18. Freed, W. J. Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects. Neurosci. Biobehav. Rev. 18:111-120; 1994.
19. Garcia-Munoz, M.; Young, S. J; Groves, P. M. Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation. Brain Res. 551:195-206; 1991.
20. Gruenewegen, H. J.; Berendse.; H. W., Meredith, G. E.; Heber, S. N.; Vourn, P.; Wolters, J. G.; Lohman, A. H. M. Functional anatomy of the ventral, limbic system-innervated striatum. In: Wilner, P.; Scheel-Kruger, J., eds. The mesolimbic dopamine system: From motivation to action. Wiley, Chichester; 1990: 19-59.
21. Harris, G. C.; Aston-Jones, G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371(8):155-157; 1994
22. Himmelsbach, C. K. Clinical studies of drug addiction: Physical dependence, withdrawal and recovery. Arch. Intern. Med. 69:766-772; 1942.
23. Jaskiw, G. E.; Karouk, F.; Freed, W. J.; Phillips, I.; Kleinman, D. H.; Weinberger, D. R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res. 534:263-272; 1990.
24. Johnson, S. W.; North, R. A. Opioids excite dopamine neurons by hyper-polarization of local interneurons. J. Neurosci. 12:483-490; 1992.
25. Karler, R.; Calder, L. D. Excitatory amino acids and the actions of cocaine. Brain Res. 582:143-149; 1992.
26. Keefe, K. A.; Zigmond, M. J.; Abercrombie, E. D. Excitatory amino acid receptor involvement in the regulation of striatal extracellular dopamine. Ann. N. Y. Acad. Sci. 604: 614-616; 1990.
27. Khanna, J. M.; Shah, G.; Weiner, J.; Wu, P. H.; Kalant, H. Effect of NMDA receptor antagonists on rapid tolerance to ethanol. Eur. J. Pharmacol. 230:23-28; 1993.
28. Koob, G. F. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trend Pharmacol. 13:177-184; 1992.
29. Matthews, R. T.; German, D. C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neurosci. 11:617-623; 1984.
30. Paxino, G.; Watson, C. The brain in stereotaxic coordinates, 2nd ed. Orlando: Academia Press; 1986.
31. Pothos, E.; Radopamine, P.; Mark, G. P.; Hoebel, B. G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566:348-350; 1991.
32. Satoh, M.; Zieglgansberger, W.; Herz, A. Supersensitivity of cortical neurons of the rat to acetylcholine and L-glutamate following chronic morphine treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 293:101-108; 1976.
33. Sesack, S. R.; Pickel, V. M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:266-271; 1988.
34. Sesack, S. R.; Pickel, V. M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens sepi and on dopamine neurons in the ventral tegemental area. Brain Res. 506:166-168; 1990.
35. Scharater, P. R.; Russo, A. C.; Stanton, T. L.; Newman, J. R.; Rodriguez, L. M.; Beckman, A. L. Changes in striatal dopamine metabolism during the development of morphine physical dependence in rats: Observations using in vivo microdialysis. Life Sci. 52:1535-1545; 1993.
36. Sloviter, R. S. Decrease hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235:73-76, 1987.
37. Thollander, M.; Hellstrom, P. M.; Svensson, T. H. Suppression of small intestinal motility and morphine withdrawal diarrhea by clonidine: peripheral site of action. Acta. Physiol. Scand. 137:385-392; 1989.
38. Thompson, T. L.; Moss, R. L. In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex. Brain Res. 686:93-98, 1995.
39. Trujillo, K. A.; Akil, H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87; 1991.
40. Tung, C. S.; Grenhoff, J.; Svensson, T. H. Morphine withdrawal responses of rat locus coeruleus neurons are blocked by an excitatory amino acid antagonist. Acta Physiol. Scand. 138:581-582; 1990.
41. Wu, W. H.; Hwang, N. G.; Tseng, C. J., Yin, T. H., Tung, C. S. Effect of prefrontal cooling on levels of glutamate, DOPAC and 5-HIAA in nucleus accumbens and striatum in vivo. Chin. J. Physiol. 36(1):1-6; 1993.
42. Zetterstrom, T.; Sharp, T.; Collin, A. K.; Ungerstest, U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:327-334; 1988.
43. Zhang, T.; Feng, Y.; Rockhold, R. W.; Ho, I. K. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55:PL 25-32; 1994.